Sinovac Biotech (SVA) Net Income Attributable to Noncontrolling Interests (2009 - 2020)
Sinovac Biotech (SVA) reported Net Income Attributable to Noncontrolling Interests of -$139.16 million for FY2025, compared with -$58.45 million in FY2024.
Powered by 
Analysis
Sinovac Biotech (SVA) Net Income Attributable to Noncontrolling Interests (2009 - 2020) Analysis & Trends
Dating back to FY2009, Sinovac Biotech's Net Income Attributable to Noncontrolling Interests record includes 17 years.
- The FY2025 figure ranks as the lowest annual Net Income Attributable to Noncontrolling Interests in data going back to FY2009.
- According to Business Quant data, Net Income Attributable to Noncontrolling Interests came in at -$58.45 million in FY2024, $111.51 million in FY2023 (-66.4%), $331.67 million in FY2022 (-94.5%) and $6 billion in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -63.87 Mn |
| Sep 30, 2020 | -9.99 Mn |
| Jun 30, 2020 | -765,000.00 |
| Mar 31, 2020 | 1.54 Mn |
| Dec 31, 2019 | -9.63 Mn |
| Sep 30, 2019 | -3.90 Mn |
| Jun 30, 2019 | 12.25 Mn |
| Mar 31, 2019 | -1.81 Mn |
| Dec 31, 2018 | -1.46 Mn |
| Sep 30, 2018 | -4.39 Mn |
| Jun 30, 2018 | -4.66 Mn |
| Mar 31, 2018 | -3.83 Mn |
| Dec 31, 2016 | -2.50 Mn |
| Sep 30, 2016 | -1.01 Mn |
| Jun 30, 2016 | 3.33 Mn |
| Mar 31, 2016 | 560,000.00 |
| Dec 31, 2015 | -243,000.00 |
| Sep 30, 2015 | 700,000.00 |
| Jun 30, 2015 | -1.19 Mn |
| Mar 31, 2015 | 589,000.00 |
API Access
Sinovac Biotech Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();